These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 6980371)
1. Increased circulating Ia-bearing T cells in HBsAg-positive chronic active hepatitis. Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M N Engl J Med; 1982 Aug; 307(8):501-2. PubMed ID: 6980371 [No Abstract] [Full Text] [Related]
2. [Chronic persistent HBsAG positive hepatitis in children. I. Subpopulations of T and B lymphocytes]. Masi M; Paolucci P; Timoncini G; Fantini MP; Chiodo F; Franceschi C Boll Ist Sieroter Milan; 1978 Sep; 57(4):464-70. PubMed ID: 310685 [TBL] [Abstract][Full Text] [Related]
3. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Colucci G; Colombo M; Del Ninno E; Paronetto F Gastroenterology; 1983 Nov; 85(5):1138-45. PubMed ID: 6225691 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers. Alexander GJ; Mondelli M; Naumov NV; Nouriaria KT; Vergani D; Lowe D; Eddleston AL; Williams R Clin Exp Immunol; 1986 Mar; 63(3):498-507. PubMed ID: 2940037 [TBL] [Abstract][Full Text] [Related]
5. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations. Ponzetto A; Arrigoni A G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950 [TBL] [Abstract][Full Text] [Related]
7. Active rosette-forming lymphocytes in chronic hepatitis. Stanciu L; Urcan S; Părău N; Radu D; Popescu S Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551 [TBL] [Abstract][Full Text] [Related]
8. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients. Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020 [TBL] [Abstract][Full Text] [Related]
9. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis. Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030 [TBL] [Abstract][Full Text] [Related]
10. [Relations between HBsAg persistence and chronicity of acute viral hepatitis]. Stanciu L; Urcan S; Părău N; Radu D; Cîrstina D; Popescu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(5):447-50. PubMed ID: 6134321 [No Abstract] [Full Text] [Related]
11. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438 [TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726 [TBL] [Abstract][Full Text] [Related]
20. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg. Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080 [No Abstract] [Full Text] [Related] [Next] [New Search]